ArticleAJOG global reports2026
A comparative analysis of blood pressure categorization using 24-hour ambulatory blood pressure monitoring in young women with presumed chronic hypertension with and without a history of pregnancy.
Article in AJOG global reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension among childbearing-age women is often underrecognized, undertreated, and when diagnosed, misclassified. Accurate diagnosis of hypertension is imperative, especially in cases of pregnancy because it directly influences medical management, delivery plan, and treatment decisions.
objectiveThis study aimed to assess the 24-hour ambulatory blood pressure monitoring results of women from the MyHEART trial who had a presumed clinical diagnosis of chronic hypertension, and to determine the incidence of masked, white coat, nocturnal, and confirmed hypertension. Secondarily, we also assessed self-reported pregnancy history and the impact of having a prior pregnancy with or without hypertension on their 24-hour ambulatory blood pressure monitoring results. STUDY
designWe conducted a secondary analysis of the data from 221 women who completed 24-hour ambulatory blood pressure monitoring during a preenrollment visit to confirm eligibility for the MyHEART trial. All women, regardless of whether they enrolled in the trial, were interviewed via phone about their history of pregnancy, hypertensive disorders of pregnancy, and/or antihypertensive medication use. Statistical analysis was performed using R software and Mann-Whitney-Wilcoxon and chi-square tests.
resultsAmong 221 women, 142 (64.3%) had confirmed chronic hypertension, 73 (33.0%) had white coat hypertension, 56 (25.3%) had nocturnal hypertension, and 43 (19.5%) had masked hypertension according to 24-hour ambulatory blood pressure monitoring results. The incidence of confirmed chronic, white coat, masked, or nocturnal hypertension in the 55 women with a history of pregnancy did not differ significantly compared with women without a history of pregnancy. Additionally, 47 of the 55 women reported hypertension during pregnancy, but their ambulatory blood pressure monitoring results were not affected by the specific hypertensive diagnosis assigned during pregnancy. Within this subgroup, the ambulatory blood pressure monitoring results varied by race. On average, Black women had significantly higher ambulatory systolic blood pressure readings and an increased incidence of nocturnal hypertension compared with their White counterparts.
conclusionThe integration of diagnostic tools such as 24-hour ambulatory blood pressure monitoring or, alternatively, home blood pressure monitoring for women with elevated blood pressures-particularly those of childbearing age-allows for more precise classification of hypertension. Accurate diagnosis supports optimal medical management and treatment decision-making, including during pregnancy, and helps avoid unnecessary interventions in individuals with white coat hypertension. Ultimately, improved diagnostic clarity enhances our ability to deliver tailored, evidence-based care by providing a more nuanced understanding of each patient's blood-pressure profile.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.